Verfolgen Sie die neuesten Nachrichten aus den Bereichen Consumer Healthcare, Pharma Rx, Kosmetik, Nahrungsergänzungsmittel, FMCG, Großhandel, Einzelhandel und Produktion! (Auf Englisch)
CPC ist ein Expertenteam mit langjähriger Erfahrung in den Bereichen Strategie & Marketing, Aufbau eines internationalen Geschäfts, Lizenzierung, M&A, Regulierung, Registrierung, Veröffentlichungen, Suche nach Führungskräften und mehr! (Auf Englisch)
CPC Publication Services bietet genaue analytische Daten, die es uns ermöglichen, unseren Kunden wichtige aktuelle Informationen und tiefe Einblicke in die Trends der Pharma- und OTC-Branche zu geben. (Auf Englisch)
Wir von Chameleon Pharma Consulting sind die Experten mit mehr als 20 Jahren Erfahrung in Bereichen wie Consumer Healthcare, Pharma Rx, Kosmetik, Nahrungsergänzungsmittel, FMCG, Großhandel, Einzelhandel, Produktion. (Auf Englisch)

ASEAN – Medical Device Directive: Practical Market Entry Roadmap for MedTech Companies
ASEAN’s medical device market is creating new market entry and partnership opportunities for global MedTech companies. This article explores AMDD, local distributors, and growth opportunities across key ASEAN markets, helping business development managers identify regulatory and expansion priorities. ...

Poland’s Generics Market 2040: Pricing Pressure and Entry Opportunities in Rx & OTC
Poland’s Rx & OTC market is one of the largest and most mature in Central and Eastern Europe, driven by high generics penetration, expanding pharmacy networks, and rising healthcare demand. With steady long-term growth expected through 2040, the market offers attractive opportunities for international companies seeking to enter a cost-conscious yet innovation-oriented healthcare landscape....

Switzerland Consumer Health and Pharma Market Overview: 2040 Growth Outlook
Total pharma and OTC sales are projected to grow from approximately USD 10.56 billion in 2030 to USD 17.8 billion by 2040, representing a CAGR of 5.36%. Market growth is supported by demographic trends...

Turkey OTC Market Development: Consumer Healthcare Trends and Market Outlook to 2040
With more than 85 million consumers, an increase in the self-medication trend, and a projected market size of USD 2.4 billion in 2040, Turkey represents a promising hub for healthcare companies wanting to internationalise....

Global Phytotherapy Market Growth: 5 Demand Trends Reshaping Consumer Healthcare Companies towards 2040
The herbal medicine market is projected to grow towards approximately USD 835.67 billion by 2040, highlighting the long-term potential of the phytotherapy market....

Mexico’s Maternal Healthcare Products: A Growing Opportunity for Consumer Health Companies towards 2040
Mexico’s large maternal care base continues to support demand for pregnancy supplements and women’s health products. According to INEGI, Mexico registered 1.67 million births in 2024, equal to 47.7 births per 1,000 women of fertile age. This creates regular demand for prenatal vitamins, folic acid, iron, calcium, DHA, and other Food Supplements supporting pregnancy, maternal wellbeing, and postpartum recovery....

Japan Medical Device Market Access: How to Navigate a Large but Complex Regulatory Landscape
Japan’s Medical Device market is currently standing at USD 34.24 billion in 2025 and could reach approximately USD 60.7 billion by 2035. For Medical Device (MedTech) companies, this creates strong opportunities, but regulatory complexity, MAH requirements and reimbursement planning remain critical for market access....

Why South Korea Dominates the Global Aesthetic Medicine Market: Trends, Innovation, and Growth
South Korea’s aesthetic medicine market is projected to reach USD 8,57 billion by 2033, growing at a CAGR of 14.6% between 2026 & 2033. Combined with strong medical tourism inflows and high demand for non-surgical procedures, the country continues to define global standards in aesthetic medicine...

Spain’s Pharmacy Networks: How Distribution Structures Rx & OTC Market Access
Spain’s total pharma sales are expected to reach USD 50,02 billion in 2040, making it a strategic market to enter. However, understanding pharmacy networks is key as they are not just distribution channels, but gatekeepers of market access....

Thailand Women’s Health: Why Maternal Nutrition Is Becoming a Strategic Focus in ASEAN
Thailand’s Consumer Health and Pharma market is expanding toward USD 14B by 2040, but growth is no longer uniform. Women’s health and pregnancy supplements are emerging as high-value niche shaping market entry strategy....

Inside Brazil Women’s Health OTC Pharma Market: Key Segments and Growth Trends by 2040
Brazil’s women health segment is evolving rapidly, supported by increasing awareness of reproductive health, expanding consumer access to OTC solutions, and growing demand for preventive and self-care products across key segments....

The French OTC Market toward 2040: $17.6B Growth Trends and Regulatory Landscapes
France’s self-medication market is steadily expanding, supported by a growing focus on preventive healthcare and consumer-driven wellness. The OTC segment is projected to grow at a CAGR of approximately 6.5% through 2040....

Winning in Germany’s Pharma Generics Market: How Rebate Contracts Control Access, Pricing, and Market Growth to 2040
Germany’s pharma market expected to grow over USD 140B in 2040, with generics alone reaching over USD 22B, yet access is no longer driven by price alone. Rebate contracts now determine which companies win scale, and which are excluded....

Vietnam’s Aesthetic Medicine Market: Technology, Personalization, and Growth till 2035
Vietnam’s aesthetic medicine market exceeds USD 355M and is growing at 8.6% CAGR through 2035, driven by a rapidly expanding middle class who represents the core customer base for aesthetic medicine procedures....

Global Women’s Health Trends: Natural Solutions for Menopause & UTI Prevention, A Growing Opportunity Beyond Antibiotics
Women’s health is one of the fastest-growing segments in the global OTC and consumer healthcare market, especially in menopause management and UTI prevention. The sector is expected to grow at around 7% CAGR globally over the next decade....